MHRAgovuk @MHRAgovuk · 31 Jul 2026
🔁Faster access to treatments, without compromising safety. Our approval of aficamten this week, alongside NICE, marks an important milestone for patients with obstructive hypertrophic cardiomyopathy, made possible through strengthened collaboration across the health system.
1 559Views
3Likes
0Reposts
5Replies
0Quotes
0Bookmarks
Is that a lot?
1.16×vs this author's median1 347 views is typical
50Percentile for this authorof 6 recent posts
0.57×vs 10K–100K median2 743 views is typical
5.17%Reachviews ÷ followers
0.51%Engagement rateof viewers reacted